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Abstract
Ischemic stroke (caused by thrombosis, embolism or vasoconstriction) lead to the recruitment and activation of
immune cells including resident microglia and infiltrating peripheral macrophages, which contribute to an
inflammatory response involved in regulation of the neuronal damage. We showed earlier that upon pro-inflammatory
stimuli, the orderly activation of caspase-8 and caspase-3/7 regulates microglia activation through a protein kinase C-δ
dependent pathway. Here, we present in vivo evidence for the activation of caspase-8 and caspase-3 in microglia/
macrophages in post-mortem tissue from human ischemic stroke subjects. Indeed, CD68-positive microglia/
macrophages in the ischemic peri-infarct area exhibited significant expression of the cleaved and active form of
caspase-8 and caspase-3. The temporal and spatial activation of caspase-8 was further investigated in a permanent
middle cerebral artery occlusion mouse model of ischemic stroke. Increasing levels of active caspase-8 was found in
Iba1-positive cells over time in the peri-infarct area, at 6, 24 and 48 h after artery occlusion. Analysis of post-mortem
brain tissue from human subject who suffered two stroke events, referred as recent and old stroke, revealed that
expression of cleaved caspase-8 and -3 in CD68-positive cells could only be found in the recent stroke area. Analysis of
cleaved caspase-8 and -3 expressions in a panel of human stroke cases arranged upon days-after stroke and
age-matched controls suggested that the expression of these caspases correlated with the time of onset of stroke.
Collectively, these data illustrate the temporal and spatial activation of caspase-8 and -3 in microglia/macrophages
occurring upon ischemic stroke and suggest that the expression of these caspases could be used in neuropathological
diagnostic work.
Keywords: Microglia, Macrophage, Caspase-8, Caspase-3, Ischemic stroke, Human brain tissue, pMCAO model, Spatio-
temporal activation
Abbreviations: CNS, Central nervous system; DAMPs, Danger-associated molecular patterns; HE, Hematoxylin-eosin;
IF, Immunofluorescence; IHC, Immunohistochemistry; LFB, Luxol fast blue/cresyl violet; MM, Microglia/macrophages;
pMCAO, Permanent middle cerebral artery occlusion; Q-VD-OPh, Quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-
methylketone
Introduction
Every year, an estimate of 15 million people worldwide
suffers a stroke. As a result, nearly six million people die
and an almost equal number of survivors are left with
long-term disabilities [1, 2]. Stroke is an acute cerebro-
vascular accident, which occur due to deranged blood
supply to the brain. There are two main types of stroke:
ischemic, due to lack of blood flow, and hemorrhagic,
due to bleeding. Ischemic stroke, which is caused by a
vessel obstructive thrombosis, embolism or vasocon-
striction, accounts for over 80 % of all incidents, is the
focus of the present study [1–3].
A decrease or reduction in blood flow results in hyp-
oxia and glucose deprivation, which can lead to neuronal
damage and cell death. The center of the ischemic area,
the ischemic core, is most affected by the reduction in
blood flow and also suffers the more instant and severe
damage of the tissue. The area surrounding the ischemic
region, the penumbra, can receive low levels of blood
flow from adjacent vascularized areas, resulting in slower
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development of neuronal damage. Injured and dying
cells release damage-associated molecular patterns
(DAMPs), which activate an immune response that is a
major contributor to stroke pathophysiology. In fact, the
immune response to acute cerebral ischemia triggers an
inflammatory reaction that may last up to several
months and plays a critical role in mediating post-
ischemic damage of the tissue and secondary neurode-
generation in the penumbra [4].
The infiltration of blood-borne immune cells facili-
tated by disruption of the blood–brain barrier integrity
following brain ischemic injury contributes to the neuro-
inflammation process. Nevertheless, the brain’s initial in-
flammatory response to ischemic event is primarily
thought to be mediated by microglia, the brain resident
immune cells. Microglia are highly dynamic cells, which
constantly scavenge the brain for potential threats and
can get rapidly activated upon detection of insults to the
brain, danger-signals or changes in the brain microenvir-
onment [5]. In response to the tissue damage, microglia
become activated and migrate to the ischemic area.
Microglia are a predominant source of proinflammatory
mediators including cytokines (e.g. tumor necrosis factor
and interleukin-1β), complement factors, free radicals,
nitric oxide (NO), chemokines (e.g. CCL2 and CCL3)
and prostaglandins, all of which potentially contribute to
further neuronal dysfunction and death [6, 7].
Suppression of neuroinflammation using a variety of
drugs were proven to be successful in reducing infarct
volume and improving outcomes in experimental
models of stroke [8]. Despite these promising preclinical
trials, up to date, clinical trials using anti-inflammatory
agents have failed to improve clinical outcomes [9].
Therefore, in order to revitalize interest for the thera-
peutic targeting inflammatory pathways for the treat-
ment of acute ischemic stroke there is a need for
comprehensive understanding of the time-dependent re-
cruitment and activation of inflammatory immune cells.
Caspases, a family of cysteinyl aspartate-specific prote-
ases, are best known as executioners of apoptotic cell
death and their activation are considered as a commit-
ment to cell death. However, caspases also function as
regulatory molecules for immunity, cell differentiation
and cell-fate determination [10]. We previously reported
the existence of a caspase-dependent signalling pathway
controlling microglia pro-inflammatory activation and
associated neurotoxicity. We showed that the orderly ac-
tivation of caspases -8 and -3/7, commonly known to
have executioner roles in apoptosis, can promote pro-
inflammatory activation of microglia in the absence of
cell death [11]. Additionally, we recently obtained evi-
dence that the activation of human monocytes/macro-
phages in response to a pro-inflammatory stimulus also
rely on caspase-8 function [12]. In addition, increasing
evidence strongly suggests that caspase-8 may play a
critical role in IL-1β processing, with special relevance
to the NLRP3 inflammasome activation [13]. NLRP3
inflammasome activation usually requires two signals or
steps; signal 1 (priming) leading to NF-kB activation and
signal 2 (typically ATP or nigericin) leading to NLRP3
machinery assembly (including at least NLRP3, the ASC
(PYCARD) adaptor, and caspase-1) [14]. As previously
stated, we first demonstrated the involvement of
caspase-8 in NF-kB activation (priming) in microglia in
response to diverse inflammatory stimuli [11], recently
validated using conditional caspase-8 knockout mice
specifically in the myeloid system [15]. The activation of
NF-kB is critical for upregulating the transcription of
both pro-IL-1β and NLRP3, as both are further needed
for inflammasome formation and activation. A role of
caspase-8 in mediating priming and activation of the
NLRP3 inflammasome has also been demonstrated in
primary macrophages [16]. Coimmunoprecipitation and
confocal studies have demonstrated that caspase-8 is
present in the NLRP3 inflammasome complex, where it
is believed to be involved in cleavage and processing of
procaspase-1 [13]. It is important to note that IL-1β acti-
vates T-cell-mediated innate immunity and promotes
secondary ischemic damage during the subacute phase
of ischemic brain injury [17]. Given the high number of
danger-associated molecular patterns (DAMPs) released
as a consequence of the ischemic damage, and the key
roles of caspases in regulating brain immune functions,
it is important to discern between the apoptotic and
non-apoptotic roles of caspases upon ischemic stroke.
In the present study, we investigated in vivo and in
post-mortem tissue from ischemic stroke subjects
whether caspase-8 and caspase-3 activation, key players
of the caspase-dependent signaling pathways regulating
microglia and macrophages (MMs) pro-inflammatory




Human brain tissue from stroke subjects and controls were
used in this study as approved by the Regional Ethical Re-
view Board in Lund, Sweden (Dnr 2010-196). Stroke tissue
from regions within the white matter of the frontal and
parietal lobe was examined and compared to area- and
age-matched controls. Both female and male cases were in-
cluded in the study with an average age of 75 ± 9 years for
stroke cases (n = 9) and 75 ± 11 years for controls (n = 5).
Deceased individuals referred for autopsy were examined
for stroke or/and diffuse ischemic damage in frontoparietal
white matter, judged as relevant for particular ischemia
susceptibility in the upper border zone areas. Three of
these patients died from a clinically suspected or also
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radiologically ascertained stroke within the last 24 h. In
two other patients, an older stroke was known and also de-
tected radiologically in the basal ganglia and the thalamus,
however not reported in the white matter, from where the
tissue was macroscopically identified and sampled. In four
cases found to have ischemic white matter damage, the
autopsy referrals focused on cardiopulmonary disease, in-
cluding myocardial infarcts in some cases. In the latter
individuals, macroscopic examination of the cut brain re-
vealed either clear-cut or suspected infarcts, which were
later microscopically verified. For sampling from focal
stroke, an area of approximately 10 mm2 and 5 mm thick-
ness in the immediate vicinity/border of the lesion was
taken for analysis. For diffuse ischemic damage (non-focal
lesion, no complete tissue loss) a similar amount of tissue
was sampled in the most damaged area.
The tissue was fixed in 4 % formaldehyde solution and
embedded in paraffin, in accordance with the standard
procedures within the department. Sections of 5 μm
thickness were cut with microtome and mounted on
glass slides. Tissue sections on regular slides were proc-
essed for standard/basic stainings (hematoxylin-eosin
(HE) and luxol fast blue/cresyl violet (LFB) for myelin
and cell structures. Tissue sections on positively charged
glass slides were processed for immunohistochemistry.
All brain sections were analyzed under the microscope
for clinical diagnostic purpose before inclusion in the
study.
Animals and surgery
C57BL/6 mice used in this study were obtained from the
Center of Production and Animal Experimentation
(Espartinas, Spain). Experiments were performed at the
University of Seville (Spain) in accordance with the
Guidelines of the European Union Council (86/609/EU),
following Spanish regulation for the use of laboratory
animals approved by the Scientific Committee of the
University of Seville. Animals were kept at diurnal
conditions with ad libitum access to food and water. Ex-
periments were conducted using 3-month-old male mice
(n = 13). Electrocoagulation was used to induce a per-
manent middle cerebral artery occlusion (pMCAO), as
described elsewhere [18]. Six to 48 h post pMCAO, ani-
mals were perfused with 4 % paraformaldehyde, pH 7.4,
during deep isoflurane anesthesia and brains were re-
moved and cryoprotected in sucrose. After freezing in
isopentane at −40 °C, brains were cut in 25 μm thick
coronal sections with a cryostat and mounted onto gel-
atin coated slides.
Immunohistochemistry
Deparaffination of the human tissue sections was done
using standard procedures in the department of Neuro-
pathology. The sections were boiled during 15 min in
10 mM Citrate buffer pH 6.0 for antigen retrieval. Stain-
ings were done using an automated immunostainer
(TechMateTM 500 Plus, DAKO) with DAKO Chem-
Mate Kit Peroxidase/3-3’diaminobenzidine.
Mouse tissue sections were washed and incubated for
20 min in 0.3 % hydrogen peroxide in methanol. After
washes, the sections were incubated in blocking buffer
containing 1 % goat serum (Vector) in TBS for 1 h. In-
cubation with primary antibodies diluted in 1 % goat
serum and 0.25 % Triton-X 100 in TBS for 24 h. 3 ×
10 min TBS washes was followed by incubation with bi-
otinylated secondary antibodies diluted in 0.25 % Triton-
X 100 in TBS for 2 h. Sections were thereafter incubated
with ExtrAvidin®-Peroxidase solution (Sigma) and visual-
ized with a standard diaminobenzidine/hydrogen perox-
idase reaction for 5 min.
Immunofluorescence
Deparaffination of the human tissue was done using 3 ×
5 min incubations in Xylene, followed by 2 × 10 min in
100 % ethanol, 2 × 10 min in 95 % ethanol and 3 ×
5 min in H2O.
Antigen retrieval was done for all tissue used for im-
munofluorescent staining by boiling in 10 mM Citrate
buffer pH 6.0 for 10 min at 95 °C. When sections
reached RT they were washed in TBS, before blocking in
5 % goat serum and 0.1 % Triton-X100 in TBS for 1 h.
Incubation of primary antibody diluted in blocking buf-
fer was done overnight at 4 °C. Washes in 3 × 10 min
TBS was followed by 1 h by appropriate secondary anti-
body in 0.1 % Triton-X100 in TBS in RT. Sections were
washed in TBS before 15 min incubation in 1 μg/ml
Hoechst 33342 in RT, and followed by TBS wash. Auto-
fluorescence removal reagent (#2160 Millipore) was used
for the human tissue according to manufacturer’s
recommendations.
Antibodies
Primary antibodies detecting anti-human cleaved
caspase-8 (Asp391) (18C8; #9496), anti-mouse cleaved
caspase-8 (Asp387) (D5B2; #8592), anti-human and
-mouse cleaved caspase-3 (Asp175) (5A1E; #9664), anti-
human cleaved PARP (D64E10; #5625) were purchased
from Cell Signaling Technology®, anti-human CD68
(PG-M1; #M0876) from Dako and anti-mouse Iba-1
(#NB100-1028) from Novus Biologicals and (#019-
19741) from Wako. For immunofluorescence detection,
fluorophore conjugated secondary antibodies were pur-
chased from Invitrogen, ThermoFisher Scientific. Goat
anti-rabbit Alexa Fluor®488 and goat anti-mouse Alexa
Fluor®594 were used for the human tissue analysis,
whereas donkey anti-rabbit Alexa Fluor®488 and donkey
anti-goat Alexa Fluor®594 were used for mouse tissue
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analysis. Biotinylated goat anti-rabbit IgG were obtained
from Vector Laboratories.
Tissue analysis
Analysis of human tissue by Immunohistochemistry was
done by a neuropathologist with a light microscope and
scored for presence of cleaved caspases and upregulation
of CD68 in the peri-infarct and ischemic area. Presence
of cleaved caspase-8 and -3 as well as increased CD68
was semiquantitative assessed based on staining intensity
of each antibody in both peak foci and the entire sam-
pled region. The scoring was done blinded to other clin-
ical information. Additional hematoxylin & eosin (HE)
and luxol fast blue/cresyl violet (LFB) staining of all tis-
sue was used to identify the stroke area and to evaluate
the age of the ischemic lesions. The same areas were ex-
amined for the double immunofluorescent labelling of
cells by Zeiss LSM510 and Zeiss LMS700 confocal laser
scanning microscopy equipped with inverted Zeiss Axio-
vert 200 m microscopes using Zeiss LSM 5 and Zeiss
ZEN 7.1 software.
Immunohistochemistry cell quantification
Iba1 and cleaved caspase-8 positive cells were quantified
after IHC staining. Analysis was performed using the
48 h post-occlusion time point on four animals. Two
sections per animal were quantified and 3 fields per sec-
tion were counted for each area (ischemic core, peri-
infarct area and surrounding area). The peri-infarct area
is defined as the region surrounding the ischemic core,
approximately 500 μm wide, with a distinct activation of
Iba1+ cells (illustrated in Fig. 1). The surrounding area is
the region distally outside the peri-infarct area, where
areas for quantification are selected approximately 1 mm
outside the peri-infarct area. Cells were divided after
Fig. 1 Iba1-positive myeloid cells in the ischemic peri-infarct area express cleaved caspase-8 in a pMCAO mouse model of ischemic stroke. Consecutive
frozen tissue sections of the ischemic core and the peri-infarct regions from mice after 48 h of permanent middle cerebral artery occlusion (pMCAO)
were analyzed by immunohistochemistry with a mouse specific antibody recognizing active caspase-8 when cleaved at Asp 387, or an Iba1 antibody
used to detect myeloid cells (a). Double immunofluorescent staining demonstrated the co-localization of cleaved caspase-8 and the myeloid cell
marker Iba1 (b). Scale bars represent 850 μm (a) and 300 μm (b)
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morphological appearance as ramified, hypertrophic,
amoeboid or rounded.
Results
Temporal and spatial activation of caspase-8 in Iba1-positive
myeloid cells in a pMCAO mouse model of ischemic stroke
To investigate activation of caspase-8 in microglia/mac-
rophages (MMs) upon a stroke event, a mouse model
with a permanent middle cerebral artery occlusion
(pMCAO) was used to simulate an ischemic stroke. Im-
munohistochemical labeling of Iba1 was used to detect
the MMs present in the ischemic core, peri-infarct area
and surrounding area (Fig. 1a). Active caspase-8 was de-
tected using an antibody that recognizes the mouse
caspase-8 when proteolytically activated by cleavage at
amino acid residue Asp387. Positivity for cleaved
caspase-8 was detected in the ischemic core and the
peri-infarct area (Fig. 1a) and could be associated with
the Iba1-positive cells, as illustrated with immunofluor-
escence double staining confirming expression of cleaved
caspase-8 in Iba1-positive cells upon stroke (Fig. 1b).
The brain's inflammatory response post-ischemia is
characterized by several stages, which is also reflected in
the recruitment and activation state of the involved im-
mune cells. Therefore, morphological changes were ana-
lyzed in Iba1-positive cells and related to the proximity to
the ischemic area. Early-stage activation is characterized
by increased ramification of cytoplasmic processes and
cell size and enhanced Iba1 labeling. This is followed by
further thickening of processes and retraction of finer
ones and increased cell body size, to end with complete
retraction of cytoplasmic processes to acquire an
amoeboid-shape morphology. Quantifications of Iba1-
positive cells revealed highest numbers of ramified or
hypertrophic cells in the surrounding area, with increasing
numbers of amoeboid cells in the peri-infarct area and of
rounded cells in the ischemic core, indicating higher de-
gree of activation of cells in the proximity to the ischemic
area (Fig. 2a-c). Interestingly, these morphological changes
could even be visualized with the cleaved caspase-8 stain-
ing and quantified after morphological appearance. Here
the largest number of cleaved caspase-8 positive cells dis-
played an amoeboid and rounded morphology and were
present in the peri-infarct area and in the ischemic core at
48 h post occlusion (Fig. 2a-b and d). The temporal aspect
of caspase-8 activation in MMs was investigated during
the acute and subacute phase of inflammation, using mur-
ine brain tissue samples analyzed at 6, 24 and 48 h post ar-
tery occlusion. Morphological changes indicative of an
activation of the Iba1-positive MMs were observed already
at 6 h in the peri-infarct area, but were even more
prominent at 24 and 48 h after occlusion (Fig. 3a). The
contralateral side of the brain was used for comparison of
the occurring changes in terms of cell numbers and mor-
phological changes of the cells close to the ischemic area.
Very low levels of cleaved caspase-8 could be detected at
Fig. 2 Expression of active caspase-8 correlates with the morphological transformation of Iba1-positive myeloid cells. Schematic overview of the
distribution of myeloid cells in the 1) ischemic core 2) peri-infarct area and 3) surrounding area (a). Cell morphologies were divided into ramified,
hypertrophic, amoeboid and rounded to reflect the states of activation. Examples of the different cell morphologies are given as cartoon and upon
immunohistochemical staining for cleaved caspase-8 (b). Morphological quantifications of Iba1-positive cells (c) and cleaved caspase-8-positive cells (d)
defined as cells per mm2 in the ischemic core (1), peri-infarct area (2) and surrounding area (3) in tissue from mice (n = 4) upon 48 h of pMCAO
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the 6 h’ time point in the peri-infarct area, but those levels
were found to be significantly increased at 24 and 48 h’
time point (Fig. 3a). Double immunofluorescence staining
for cleaved caspase-8/Iba1 and confocal imaging illus-
trated that cleaved caspase-8 was rarely detected at the
6 h occlusion, but more frequently in the cytosol of Iba1-
positive cells at the 24 and 48 h time points.
Expression of active caspase-8 and caspase-3 in CD68-
positive myeloid cells in stroke subjects correlates with
age of the ischemic area
We were then interested to examine if activation of the
apical caspase-8 and its downstream target caspase-3
could also be detected in MMs in human subjects who
had suffered a stroke. Post-mortem brain tissue from sub-
jects with a recent ischemic stroke was examined using
immunohistochemical stainings. CD68 was used to detect
activated MMs and revealed the presence of large num-
bers of inflammatory CD68-positive cells with rounded
macrophage-like morphology in the peri-infarct area and
ischemic core (Fig. 4a and Additional file 1a). Detection of
active caspase-8 was performed using an antibody which
recognizes human caspase-8 when cleaved at amino acid
residue Asp391 (for antibody positive controls, see Add-
itional file 2). Positive signal for cleaved caspase-8 was de-
tected in numerous cells in the stroke peri-infarct area, as
well as some positivity in the ischemic core (Fig. 4a and
Additional file 1a). Expression of activated caspase-3 was
also detected in the same areas using an antibody recog-
nizing human caspase-3 when proteolytically activated by
cleavage at amino acid residue Asp175 (Fig. 4a and
Additional file 1a). In order to validate the presence of
those active caspases in the CD68-positive cells, double
immunofluorescent labelling for CD68 and cleaved
caspase-8 or caspase-3 were performed. In fact, confocal
imaging demonstrated the presence of both cleaved
caspase-8 and cleaved caspase-3 in the cytoplasm of
CD68-positive cells, confirming the activation for those
caspases in the MMs upon stroke (Fig. 4b-c and
Additional file 1b-c). Interestingly, for two stroke cases we
Fig. 3 Temporal activation of caspase-8 in Iba1-positive myeloid cells. Frozen tissue sections from mice upon pMCAO (n = 9) were analyzed by
immunohistochemistry for expression of active caspase-8 or for expression of the microglia/macrophage marker Iba1. The contralateral side to
the ischemic area was used an internal control for each animal. A small increase in body size of Iba1 positive cells was detected in the peri-infarct
area at 6 h, with larger increase in cell body and numbers of cells expressing Iba1 detected at 24 and 48 h post occlusion (a). Cleaved caspase-8
was detected at low levels at 6 h, but a significant increase in expression levels was observed at 24 and 48 h in the peri-infarct area, but not at
the contralateral side (a). Double immunofluorescent staining revealed that increased active caspase-8 expression was localized in Iba1-positive
cells (b). Scale bar represent 100 μm in IHC images (a) and 10 μm in IF images (b)
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Fig. 4 Presence of active caspase-8 and caspase-3 in CD68-positive cells correlates with age of the ischemic area. Paraffin imbedded brain tissue
sections from subjects who suffered from two strokes, referred as recent and old stroke areas, were analyzed by immunohistochemistry for active
caspase-8 and caspase-3 expressions using antibodies raised against caspase-8 when cleaved at Asp391 and human caspase-3 when cleaved at
Asp175 and compared to healthy control tissue. Cleaved caspase-8 and -3 were detected in tissue from the recent stroke area, but not in healthy
control tissue (a). Numbers and levels of CD68-positive cells were markedly increased in recent stroke tissue as compared to control (a), and
found to be positive for cleaved caspase-8 and -3 using double immunofluorescence staining analyses (b-c). In contrast, for the older stroke area,
lower levels of CD68 were detected as well as very low level/absence for cleaved caspase-8 and -3 (a). Immunofluorescence analysis confirmed
the decrease/absence of active caspase-8 and -3 in the CD68-expressing cells within the older stroke area (b-c). Scale bar for IHC images
corresponds to 100 μm (a) and for IF images 10 μm (b-c)
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also got the opportunity to analyze tissue samples from an
older stroke area within the same cases. The subjects who
had suffered two different stroke events are hereafter re-
ferred to as recent and old stroke. In contrast to the recent
stroke, investigation of the older stroke area revealed low
number and levels of CD68-positive cells still present
around the ischemic area (Fig. 4a and Additional file 1a,
compare middle “recent stroke area” with “old stroke
area” rows). Expression for cleaved caspase-8 and caspase-
3 was barely detected in the peri-infarct at this stage.
Double staining for the markers confirm the absence/low
levels of these active caspases in remaining CD68-positive
cells (Fig. 4a and Additional file 1a, compare middle “re-
cent stroke area” with “old stroke area” rows).
Under cell death conditions, activated caspase-8 is
known to cleave and activate caspase-3, which in turn can
cleave PARP and contribute to the demise of the cell. To
demonstrate absence of a caspase-dependent cell death in
the CD68-positive myeloid cells, tissue from control sub-
jects and recent stroke areas in patients were labelled with
antibodies detecting cleaved PARP and CD68. We could
not detect PARP cleavage in CD68 positive cells either in
the ischemic core or peri-infarct area after stroke, indicat-
ing that the caspase activation in these cells is not linked
to cell death (Fig. 5). PARP cleavage was, however, de-
tected in the colon tissue used as positive control (Fig. 5).
In a panel of 9 subjects who had suffered a stroke, post
mortem tissue from 10 different stroke areas of various
ages (i.e. time after stroke onset) were examined. Evaluation
of the tissue by hematoxylin and eosin staining was used to
detect and determine the age of the stroke areas (not in-
cluded in manuscript). In addition, five area and age-
matched controls were also included in the investigation.
Immunohistochemical staining for CD68, active caspase-8
and active caspase-3 was performed as described above.
Scoring of the tissue for expression of the different markers
was done by an experienced neuropathologist. The follow-
ing scale was used for scoring: not present (-), present (+)
or high levels (++) of active caspases. In the human stroke
subjects, highest levels of active caspase-8 and active
caspase-3 could be detected the first day after the stroke,
and then slowly decreases with time until complete dis-
appearance after 5–29 days after the ischemic event
(Table 1). CD68-positivity was reported as upregulated
(Yes) or basal/very low levels (No). The high numbers of
CD68-positive cells were, as the caspases, detected at the
earlier time points after the ischemic event, but declined
with time and are back to basal levels (as compared to con-
trols) in most subjects after 5–29 days after onset (Table 1).
Discussion
There is compelling evidence that brain injury follow-
ing ischemic stroke develops from a complex series of
pathophysiological events that evolve in time and
space [19, 20]. After an ischemic stroke, experimental
and clinical data suggest that a prominent inflamma-
tory response develops, propagates, and lasts for
many days, and is believed to exacerbate neuronal cell
death [21, 22].
The brain’s initial inflammatory response to stroke is
proposed to be primarily mediated by microglia, the
resident immune cells of the CNS. However, within mi-
nutes or hours of the stroke event, the blood–brain bar-
rier is compromised and infiltration of monocytes,
neutrophils and lymphocytes occurs [23, 4, 24]. The
brain-resident (microglia) and infiltrating peripheral
(monocytes) myeloid cells have a prominent role in initi-
ating, sustaining and resolving post-ischemic inflamma-
tion. It is therefore of importance to elucidate the
molecular mechanism regulating their activation. Our
team previously described an unexpected novel function
for caspases in the control of microglia activation and
thereby neurotoxicity. We showed that orderly activation
Fig. 5 Absence of cleaved PARP, marker for apoptosis, in CD68-positive
myeloid cells in stroke subject. Tissue from recent stroke case and healthy
control subjected to double immunofluorescence staining using
antibodies raised against CD68 and cleaved PARP, revealed an absence
for the apoptosis marker in CD68-expressing myeloid cells. Tissue from
colon was used as positive control for the cleaved PARP staining.
Overview of the peri-infarct area of stroke case is depicted on top panel,
whereas higher magnification images for both stroke case and controls
are presented in the lower panels. Scale bars in images represent 10 μm
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of caspase-8 and caspase-3 regulates microglia activa-
tion, in the absence of cell death [11]. In addition, we re-
cently obtained evidence that caspase-8 regulates the
activation of human monocytes [12]. Considering the
central role played by these caspases in the activation of
microglia/monocytes, and the contribution of these cells
in the observed inflammatory response following ische-
mic stroke, we decided to investigate whether activation
of these caspases follow spatial and temporal features.
Immunohistochemical staining, as well as immunofluor-
escence confocal imaging, of post-mortem tissues from
subjects who had suffered an ischemic stroke, was used
with a CD68-antibody to detect activated myeloid cells.
Additional staining with cleaved caspase-8 or cleaved
caspase-3 revealed that myeloid cells in the ischemic core
and peri-infarct area expressed active caspase-8 and
caspase-3. It is believed that non-apoptotic functions of
caspases rely on a moderate activity and a restricted sub-
cellular localization. We have demonstrated that a differ-
ential processing of caspase-3 zymogen may ultimately
lead to apoptosis (caspase-3 subunit p17; nuclear
localization) or microglia activation (caspase-3 subunit
p19; cytosolic localization) [25]. Our confocal analysis
demonstrated a non-nuclear localization of active caspase-
3 within myeloid cells early after stroke, a view that fits
well with the non-apoptotic role of caspases in regulating
myeloid cell activation. Analysis of brain tissue samples
from a pMCAO mouse model of ischemic stroke, at 6, 24
and 48 h post artery occlusion, illustrated a temporal and
spatial activation for caspase-8 in Iba1-positive myeloid
cells. Indeed, increased levels for cleaved caspase-8 stain-
ing were found to correlate with morphological changes
of the Iba1-positive cells from ramified cells to amoeboid
or rounded shapes in proximity to the ischemic core. Not-
ably, this correlation was particularly evident in the peri-
infarct area, a region revealing penumbra like conditions
and is potentially salvable upon a brain infarct, in contrast
to the stroke core where perfusion is completely absent
and irreversible loss of tissue (infarction) occurs within
minutes [26]. It has been long established that microglia
activation is particularly evident in the penumbra region
in response to ischemic damage [19]. Although the contri-
bution of the inflammatory response to ischemic brain in-
jury is under debate, increasing evidence points out a
deleterious role. For instance, recent data have demon-
strated how microglia in the penumbra region is strongly
associated with blood vessels; reactive microglia phagocyt-
ose endothelial cells, thus contributing to BBB disruption
and neurodegeneration [27]. In the present study we dem-
onstrate the potential contribution of caspases in regulat-
ing brain immune function in the peri-infarct penumbra-
like region. The multifaceted roles of caspase-8 make this
caspase very attractive in the context of future stroke
strategies aimed at minimizing brain injury. These
varied roles include i) it controls microglia activation
through a caspase-3/NF-kB-dependent mechanism,
with the subsequent release of neurotoxic proinflam-
matory cytokines [11], ii) recent data suggest a prom-
inent role of this caspase in the priming and
activation of inflammasomes [13], iii) inflammasome
activation may lead to pyroptosis, a proinflammatory
and lytic mode of cell death and iiii) caspase-8 nega-
tively regulates programmed necrosis or necroptosis,
which relies of a molecular platform known as necro-
some and strongly associated to immune cells of mye-
loid origin including microglia, monocytes and
macrophages [28]. Since the repair process for dam-
aged brain tissues and regeneration of neural cells
takes place during resolution of inflammation [17],
and having demonstrated that active caspase-8 is
mostly confined to reactive myeloid cells in the peri-
infarct region, we anticipate that site-directed delivery
of caspase-8 inhibitors under stroke conditions may
hinder microglia activation and affect microglia sur-
vival. Finally, our analysis of post-mortem tissues
from subjects who suffered two independent ischemic
stroke events, as well as the examination of panel of
Table 1 Temporal expression of active caspase-8 and caspase-3









Case 1 ++ ++ Yes 0–1
Case 2 ++ + Yes 0–1
Case 3 + + Yes 0–1
Case 4 + + Yes 1–4
Case 5 + – Yes 1–4
Case 6 + – Yes 5–29
Case 7a + – No 5–29
Case 8 + – No 5–29
Case 7b – – No 30–
Case 9 – – No 30–
Control 1 – – No
Control 2 – – No
Control 3 – – No
Control 4 – – No
Control 5 – – No
Tissue from 10 different areas from stroke subjects (Case; n = 9) and 5 areas
from healthy controls (n = 5) were analyzed for CD68, cleaved caspase-8 and
cleaved caspase-3 expression by immunohistochemistry (exemplified in Fig. 4a).
Cleaved caspase-8 or -3 expression levels were scored as (-) not present, (+)
present or (++) high levels. CD68 expression was represented as (No) not
present/basal levels or (Yes) increase in CD68 positive cells. Age of stroke area
was determined by hematoxylin and eosin staining and is presented as days
after stroke event. Highest levels of cleaved caspase-8 and-3 expressions were
found within the first days after stroke. They were found to decrease with
time, and were completely gone within 30 days. CD68-positive cells can be
found at high numbers within the first days after stroke and decrease to basal
levels within 30 days after stroke onset
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10 different stroke areas of various ages (i.e. time
after stroke onset) suggested that the presence of ac-
tive caspase-8 and -3 in CD68-positive cells correlates
with the age of ischemic area.
The approximate time after stroke onset can be deter-
mined by neuropathologists and forensic pathologists by
the postmortem analysis of ischemic lesions. Parameters
used may include analysis of inflammation and myeloid
component [29, 30]. The distinct pattern of cleaved
caspase-8 surrounding the infarct in our data suggests
that immunohistochemical analysis of cleaved caspase-8
could be considered as a relevant additional diagnostic
parameter.
Whereas inhibition of caspase-8 and/or caspase-3
could be used as therapeutic strategy to combat the in-
flammatory response initiated upon ischemic stroke re-
mains controversial. Evidence for neuroprotection have
been reported with Quinolyl-valyl-O-methylaspartyl-
[-2,6-difluorophenoxy]-methylketone (Q-VD-OPh) a
third-generation broad spectrum caspase inhibitor [31],
which is able to crosses the blood–brain barrier, in ani-
mal models of stroke [32]. However, it remains to be
established whether Q-VD-OPh affects microglia/mono-
cytes activation in this disease model and contributes to
the neuroprotective effect in that manner. In addition,
Q-VD-OPh treatment has been reported to impair the
neural stem/progenitor cell response after cortical ische-
mia in mice, highlighting that caution is warranted using
such strategy [33].
Conclusion
In conclusion, we revealed the temporal and spatial acti-
vation of caspase-8 and -3 in microglia/macrophages oc-
curring upon ischemic stroke in human stroke subjects
and in a mouse model of ischemic stroke. Overall, the
report of a spatio-temporal activation of caspase-8 and
-3 in microglia/macrophages occurring upon ischemic
stroke indicates that any attempt to target the molecular
signaling regulating the detrimental inflammatory re-
sponse would have to take into account the time window
for intervention.
Additional files
Additional file 1: Figure S1. Analysis of a second subject whom suffered
from two stroke events and a healthy control. Immunohistochemical
labelling for CD68, cleaved caspase-8 and cleaved caspase-3 (a), as well as
double immunofluorescent labelling for CD68 and cleaved caspase-8
alternatively cleaved caspase-3 (b-c) in recent and old stroke areas are
depicted. IHC image scale bar corresponds to 100 μm (a) and IF images to
10 μm (b-c). (TIF 4099 kb)
Additional file 2: Figure S2. Positive controls for immunohistochemistry
antibodies. Antibodies detecting cleaved caspase-8 and cleaved caspase-3
showed positive signal in sections from human colon tissue. Antibody
detecting CD68 showed positive signal in sections from human lymph
node. Scale bar represents 100 μm. (TIF 1191 kb)
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